Definium Therapeutics
DFTX
#3515
Rank
A$5.86 B
Marketcap
A$42.82
Share price
-3.87%
Change (1 day)
158.91%
Change (1 year)

Earnings for Definium Therapeutics (DFTX)

Earnings in 2026 (TTM): -A$0.52 Billion

According to Definium Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.27 Billion a decrease over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Definium Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.52 Billion89.7%
2025 -A$0.27 Billion67.59%
2024 -A$0.17 Billion13.68%
2023 -A$0.15 Billion41.1%
2022 -A$0.11 Billion-30.4%
2021 -A$0.15 Billion215.25%
2020 -A$45.68 Million